108 related articles for article (PubMed ID: 35501256)
1. Māori and Pacific Peoples With Multiple Myeloma in New Zealand are Younger and Have Inferior Survival Compared to Other Ethnicities: A Study From the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
Moore EM; Blacklock H; Wellard C; Spearing R; Merriman L; Poplar S; George A; Baker B; Chan H; McQuilten ZK; Wood EM; Spencer A;
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e762-e769. PubMed ID: 35501256
[TBL] [Abstract][Full Text] [Related]
2. The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR).
Bergin K; Wellard C; Moore E; McQuilten Z; Blacklock H; Harrison SJ; Ho PJ; King T; Quach H; Mollee P; Walker P; Wood E; Spencer A;
Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e510-e520. PubMed ID: 33785297
[TBL] [Abstract][Full Text] [Related]
3. Ethnic disparities in the incidence and outcome from out-of-hospital cardiac arrest: A New Zealand observational study.
Dicker B; Todd VF; Tunnage B; Swain A; Conaglen K; Smith T; Brett M; Laufale C; Howie G
Resuscitation; 2019 Dec; 145():56-62. PubMed ID: 31585186
[TBL] [Abstract][Full Text] [Related]
4. Do community-dwelling Māori and Pacific peoples present with dementia at a younger age and at a later stage compared with NZ Europeans?
Cullum S; Mullin K; Zeng I; Yates S; Payman V; Fisher M; Cheung G
Int J Geriatr Psychiatry; 2018 Aug; 33(8):1098-1104. PubMed ID: 29766582
[TBL] [Abstract][Full Text] [Related]
5. Impact of the first wave of COVID-19 on the health and psychosocial well-being of Māori, Pacific Peoples and New Zealand Europeans living in aged residential care.
Cheung G; Bala S; Lyndon M; Ma'u E; Rivera Rodriguez C; Waters DL; Jamieson H; Nada-Raja S; Chan AHY; Beyene K; Meehan B; Walker X
Australas J Ageing; 2022 Jun; 41(2):293-300. PubMed ID: 34855238
[TBL] [Abstract][Full Text] [Related]
6. Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR).
Bergin K; Wellard C; Augustson B; Cooke R; Blacklock H; Harrison SJ; Ho J; King T; Quach H; Mollee P; Walker P; Moore E; McQuilten Z; Wood E; Spencer A;
Bone Marrow Transplant; 2021 Oct; 56(10):2533-2543. PubMed ID: 34011965
[TBL] [Abstract][Full Text] [Related]
7. Māori Health Outcomes in Intensive Care Following Cardiac Surgery in Aotearoa New Zealand.
Mohd Slim MA; Lala HM; Barnes N; Martynoga RA
Heart Lung Circ; 2022 Jul; 31(7):1037-1044. PubMed ID: 35249824
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer characteristics and survival differences between Maori, Pacific and other New Zealand women included in the Quality Audit program of Breast Surgeons of Australia and New Zealand.
Campbell I; Scott N; Seneviratne S; Kollias J; Walters D; Taylor C; Roder D
Asian Pac J Cancer Prev; 2015; 16(6):2465-72. PubMed ID: 25824782
[TBL] [Abstract][Full Text] [Related]
9. Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry.
Ho PJ; Moore EM; McQuilten ZK; Wellard C; Bergin K; Augustson B; Blacklock H; Harrison SJ; Horvath N; King T; Mollee P; Quach H; Reid C; Rosengarten B; Walker P; Wood EM; Spencer A
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e415-e424. PubMed ID: 31208889
[TBL] [Abstract][Full Text] [Related]
10. Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centre.
Hock BD; Mulholland KS; Ganly P; McKenzie JL; Pearson JF; MacPherson SA
Intern Med J; 2019 May; 49(5):598-606. PubMed ID: 30411451
[TBL] [Abstract][Full Text] [Related]
11. Changing survival of people with myeloma and end stage kidney disease: A cohort study using Australian and New Zealand dialysis and transplant registry 1963-2013.
Webster AC; Irish AB; Kelly PJ
Nephrology (Carlton); 2018 Mar; 23(3):217-225. PubMed ID: 28004444
[TBL] [Abstract][Full Text] [Related]
12. Treatment modalities for Māori and New Zealand European men with localised prostate cancer.
Obertová Z; Lawrenson R; Scott N; Holmes M; Brown C; Lao C; Tyrie L; Gilling P
Int J Clin Oncol; 2015 Aug; 20(4):814-20. PubMed ID: 25557325
[TBL] [Abstract][Full Text] [Related]
13. Ethnic differences in acute promyelocytic leukaemia between New Zealand Polynesian and European patients.
Varghese C; Liu VY; Immanuel T; Chien N; Green T; Chan G; Theakston E; Kalev-Zylinska M
Hematology; 2021 Dec; 26(1):215-224. PubMed ID: 33594940
[TBL] [Abstract][Full Text] [Related]
14. Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry.
Bergin K; Moore E; McQuilten Z; Wood E; Augustson B; Blacklock H; Ho J; Horvath N; King T; McNeil J; Mollee P; Quach H; Reid CM; Rosengarten B; Walker P; Spencer A
BMC Med Res Methodol; 2016 Nov; 16(1):151. PubMed ID: 27829380
[TBL] [Abstract][Full Text] [Related]
15. The establishment of a multiple myeloma clinical registry in the Asia-Pacific region: The Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR).
Aoki N; Chen PY; Chen W; Chng WJ; Gan GG; Goh YT; Hou J; Huang J; Kim K; Lee JJ; Lu J; McQuilten ZK; Min CK; Moore E; Oliver L; Waters NA; Wellard C; Wood EM; Yeh SP; Spencer A;
BMC Med Res Methodol; 2024 May; 24(1):102. PubMed ID: 38698331
[TBL] [Abstract][Full Text] [Related]
16. A multi-ethnic breast cancer case-control study in New Zealand: evidence of differential risk patterns.
Jeffreys M; McKenzie F; Firestone R; Gray M; Cheng S; Moala A; Pearce N; Ellison-Loschmann L
Cancer Causes Control; 2013 Jan; 24(1):135-52. PubMed ID: 23179663
[TBL] [Abstract][Full Text] [Related]
17. Modifiable Risk Factors and Change in Cognition of Māori and Non-Māori in Advanced Age: LiLACS NZ.
Zawaly K; Moyes SA; Buetow S; Tippett L; Kerse N
J Appl Gerontol; 2022 Jan; 41(1):262-273. PubMed ID: 33660541
[TBL] [Abstract][Full Text] [Related]
18. Widening access to veterinary education: descriptive analysis of ethnicity, societal representation and educational background of applicants to veterinary education in Aotearoa New Zealand.
Jillings E; Curtis E; Gardner D; Parkinson TJ; Hecker KG; Cogger N
N Z Vet J; 2021 May; 69(3):147-157. PubMed ID: 33754960
[TBL] [Abstract][Full Text] [Related]
19. Differences in survival between Māori and New Zealand Europeans with prostate cancer.
Lao C; Obertová Z; Brown C; Scott N; Edlin R; Gilling P; Holmes M; Tyrie L; Lawrenson R
Eur J Cancer Care (Engl); 2016 Mar; 25(2):262-8. PubMed ID: 26918691
[TBL] [Abstract][Full Text] [Related]
20. Impact of age, sex, ethnicity, socio-economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New Zealand.
Chan HSH; Milne RJ
Br J Haematol; 2020 Mar; 188(5):692-700. PubMed ID: 31584720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
